Aktuelle Kurse von ZyVersa Therapeutics, Inc. - Common Stock

Börse	Ticker	Währung	Letzter Umsatz	Kurs	Tagesveränderung	Tagesveränderung %
NASDAQ	ZVSA	USD	06.02.2025 21:57	1,24 USD	1,28 USD	-3,74 %

Performance

Heute	Woche	Monat	3 Monate	6 Monate	1 Jahr	5 Jahre
-3,74 %	-9,85 %	-0,41 %	-51,95 %	-62,00 %	-79,75 %	-99,96 %

Firmenprofil zu ZyVersa Therapeutics, Inc. - Common Stock Aktie

ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It engages in the development of VAR 200, a cholesterol efflux mediator to treat focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney disease; and IC 100, a novel inflammasome ASC inhibitor for treatment of multitude of inflammatory diseases. ZyVersa Therapeutics, Inc. is headquartered in Weston, Florida.

Unternehmensdaten

Name ZyVersa Therapeutics, Inc. - Common Stock

Firma ZyVersa Therapeutics, Inc.

Symbol ZVSA

Website https://www.zyversa.com

Heimatbörse

NASDAQ

ISIN US98987D2018

Wertpapierart Aktie

Sektor Healthcare

Branche Biotechnology

CEO Mr. Stephen C. Glover

Land Vereinigte Staaten von Amerika

Währung USD

Mitarbeiter 0,0 T

Adresse 2200 N. Commerce Parkway, 33326 Weston

IPO Datum 2022-02-11

ID Changes

Date	From	To
13.12.2022	LSPR	ZVSA

Ticker Symbols

Name	Symbol
NASDAQ	ZVSA

More Shares

Investors who ZyVersa Therapeutics, Inc. - Common Stock hold also have the following shares in their portfolio:

MORINAGA MILK IND. Share

NEXTERA CAP. 19/26 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog